Docoh
Loading...

STAA Staar Surgical

Filed: 25 Jun 21, 4:06pm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): June 24, 2021

 

 

STAAR Surgical Company

(Exact Name of Registrant as Specified in Charter)

 

 

Delaware

0-11634

95-3797439

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

25651 Atlantic Ocean Drive

Lake Forest, California

 

92630

(Address of Principal Executive Offices)

 

(Zip Code)

Registrant’s Telephone Number, Including Area Code: 626-303-7902

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common

STAA

NASDAQ

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1 933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 



 

Item 5.07.

Submission of Matters to a Vote of Security Holders

STAAR Surgical Company’s virtual annual meeting of shareholders (the “Annual Meeting”) was held on June 24, 2021. 46,894,870 shares of common stock were outstanding on the record date for the Annual Meeting (April 27, 2021) and entitled to vote at the Annual Meeting.  The voting was as follows:  

1.

To elect seven directors to serve for terms to expire in 2022 or until their successors have been elected and qualified.  

 

Number of Shares

For

Withheld

Broker Non-Votes

Stephen C. Farrell

35,880,171

165,572

3,826,833

Thomas G. Frinzi

Gilbert H. Kliman, MD

Caren Mason

36,005,324

35,919,144

36,014,432

40,419

126,599

31,311

3,826,833

3,826,833

3,826,833

Louis E. Silverman

35,623,482

422,261

3,826,833

Elizabeth Yeu, MD

36,018,165

27,578

3,826,833

K. Peony Yu, MD

36,017,978

27,765

3,826,833

 

 

 

 

 

 

 

 

2.  

To ratify the selection of BDO USA, LLP as the Company’s independent registered public accountants for the fiscal year ending December 31, 2021.  

 

Number of Shares

For

Against

Abstain

39,122,861

582,091

167,624

 

 

 

3.

To hold an advisory vote to approve STAAR’s compensation of its named executive officers.  

 

Number of Shares

For

Against

Abstain

Broker Non-Votes

35,061,105

929,457

55,181

3,826,833

 

SIGNATURE


 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

STAAR Surgical Company 

 

June 25, 2021

By:

/s/ Caren Mason

 

 

Caren Mason

 

 

President and Chief Executive Officer